RA CAPITAL MANAGEMENT, L.P. purchased $456K of ARTV (indirect holdings)
RA CAPITAL MANAGEMENT, L.P. purchased 45,768 indirectly-held shares of Artiva Biotherapeutics, Inc. (ARTV) at an average of $9.96 ($9.93–$9.99, $0.46M total) across 2 trades over 2026-07-29 to 2026-07-31.
How this was made
The 30-second read
Why it matters
The newest disclosed fact is the open-market purchase size, price range, and post-transaction share count. It does not include any operational or financial updates for Artiva.
Market read
Traders may note the disclosed buy as a positioning signal, but there is no accompanying catalyst that would justify a high-conviction trade.
What to watch
Indirect holdings and 10b5-1 status are not provided as a plan (explicitly says no pre-arranged 10b5-1), but without context on total position changes or investment mandate, the signal strength is uncertain.
Background
The article is a SEC Form 4 insider transaction disclosure for Artiva Biotherapeutics (ARTV), reported by RA Capital Management, L.P. as a 10% owner with indirect holdings.
Ticker impact
RA Capital Management filed a Form 4 showing an indirect open-market purchase of 45,768 shares of Artiva Biotherapeutics at about $9.93 to $9.99.
Likely limited, short-lived sentiment impact; no clear directional catalyst beyond positioning signal.
The filing is a Form 4 for an indirect holding by a 10% owner, with no accompanying guidance, trial, deal, or regulatory event. Such transactions often have modest market impact unless tied to a broader corporate catalyst.
Market effects
Minimal; single-company Form 4 activity does not materially change biotech sector fundamentals.
None indicated.
None indicated.
Counterpoint
The purchase may reflect routine rebalancing or pre-existing exposure rather than a new bullish thesis, so price reaction may be muted.
Key entities
- issuerArtiva Biotherapeutics, Inc.
Subject of the Form 4 insider transaction disclosure (ARTV).
- reporterRA Capital Management, L.P.
10% owner reporting an indirect open-market purchase of ARTV shares.